FDA busts 1,000 websites in counterfeit drug, medical device operation

The international operation was led by Interpol, and involved multiple centers and offices within the FDA.

The FDA took action against more than 1,000 websites that illegally sell potentially dangerous, unapproved prescription medicines and medical devices to consumers, as part of an international operation focusing on counterfeit pharmaceuticals.

According to a FDA press release, the agency sent Warning Letters to the nearly 400 websites that offer unapproved, or misbranded, prescription medicines to U.S. patients and to nine firms distributing unapproved, or uncleared, medical devices online.

In collaboration with other federal agencies, the FDA screened and seized illegal drug products and medical devices received through International Mail Facilities in Chicago, Miami, and New York during the operation. These screenings resulted in 814 parcels being detained and referred to appropriate FDA offices for follow up.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report